FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/26/2024
Back to search
Official data from USPTO
SEFIRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
02/26/2024
Trademark type
Combined
Nice classes
5
Filing date
11/24/2021
Registration date
10/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
10/31/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
85
Owner location
CH
Examiner
RIEPEL, CHRISTINA MAXINE
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording SEFIRA and a design comprising two intersecting oblongs.
Holders and representatives
Holders
Sutara SA
Representatives
Yue (Robert) Xu Apex Attorneys at Law, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsantibiotics; diagnostic preparations for medical and veterinary use; sanitary preparations for medical purposes; dietetic food and preparations adapted for medical or veterinary usefood for babies; dietary supplements for human beings and animals; plastersmaterials for medical dressings; disinfectants; adjuvants for medical purposes; cooling sprays for medical purposes; albumin dietary supplements; alginate dietary supplements; amino acids for medical purposes; amino acid preparations for medical purposes; analgesics; anaesthetics; vermifuges; anti-uric preparations; antibacterial pharmaceuticals; antiseptics; autonomic drugs for medical purposes in treating diseases or disorders related to the parasympathetic nervous system; germicides; balms for medical purposes; balsamic preparations for medical purposes; albuminous preparations being dietetic foods for medical purposes; albuminous foodstuffs for medical purposes; activated charcoal dietary supplements; biological preparations for medical purposes for the treatment of cancer; bronchodilating preparations; vaccines; vitamin preparations; vitamin and mineral preparations for medical use; lead waterdietetic beverages for treating heavy metal poisoning; mineral waters for medical purposes; dietary fibre for use as a dietary supplement; herbal remediesherbal extracts for medical purposes; homogenized food adapted for medical purposes; disinfectants for hygiene purposes; diagnostic preparations for medical purposes; dietary supplements; nutritional and dietary supplements for stress relief; antioxidants being dietary supplements; anti-cancer preparations; nutritional and dietary supplements for strengthening the immune system; dietary supplements intended to supplement a normal diet or to have health benefits; dietary supplements consisting of vitamins; royal jelly dietary supplements; glucose dietary supplements; pollen dietary supplements; dietary supplements with a cosmetic effect; linseed dietary supplements; linseed oil dietary supplements; acai powder dietary supplements; propolis dietary supplements; wheat germ dietary supplements; natural dietary supplements for treatment of claustrophobia; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; dietetic foods adapted for medical purposes; yeast dietary supplements; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; elixirs being pharmaceutical preparations for treatment of headache; enzyme dietary supplements; febrifuges; carbohydrate-based dietary supplements; blood substitutes for medical or veterinary purposes; nervines being medicines for treatment of nerve disorders; drugs for medical purposes in the treatment of nervous system disorders; recombinant drug-metabolizing enzyme being biochemical preparations for veterinary purposes; immunostimulants; casein dietary supplements; amino acids for pharmaceutical purposes; medicinal roots; depuratives for the body; lecithin dietary supplements; medicines for human purposes in the treatment of nervous system disorders; medicated candy; lotions for pharmaceutical purposes in the treatment of dermatological conditions; magnesia for pharmaceutical purposes as an antacid and dietary supplement; medicated soap; mineral food supplements; vitamins; vitamin supplement patches; medicinal drinks; medicinal infusions for treating gastrointestinal disorders; herbal tinctures for medical purposes; nutraceutical preparations for therapeutic or medical purposes as a dietary supplement; fumigating sticks; fumigation preparations for medical purposes; medicinal oils; mouthwashes for medical purposes; headache relief sticks; antioxidant food supplement pills; by-products of the processing of cereals for medical purposes including as dietetic preparations adapted for medical use; nutritional supplements; preparations in the nature of sexual stimulants for increasing sexual prowess; human immune globulin for use in autoimmune medical treatments; therapeutic drugs and agents for weight control and appetite suppression; pre-filled syringes for medical purposes sold filled with insulin; bath preparations for medical purposes; dietary supplements for animals; pharmaceutical preparations for the treatment and prevention of influenza; opotherapy preparations; preparations of trace elements in the nature of dietary and nutritional supplements for human and animal use; medicated toiletry preparations; freezedried food adapted for medical purposes; protein dietary supplements; soy protein dietary supplements; antivirals; antiarrhythmic drugs; anti-inflammatories; antiepileptic drugs; antitumor drugs; sedatives; tissues impregnated with pharmaceutical skin lotions; syrups for pharmaceutical purposes for treatment of cough and cold; medicated salts for mineral water baths; mineral water salts for medical purposes; vegan protein for use as a nutritional supplement in ready-to-drink beverages; cough pastilles for pharmaceutical purposes; therapeutic preparations for the bath; thermal watervitamin and mineral enriched water for medical purposes; tonicsmedicines for use in the treatment of cardiovascular diseases; medicinal herbs; pharmaceuticalsantihelminticspsychotropics; pharmaceutical substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycognitive disorders; ferments for pharmaceutical purposes; diarrhoea medication; phytotherapy preparations for medical purposes; dietary food supplements for medical purposes; medicated sweets; medicinal tea; asthmatic tea; herbal teas for medicinal purposes; medicated shampoos; medicated dry shampoo
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/01/2024
FIMP
FINAL DISPOSITION PROCESSED
02/01/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/31/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/15/2023
PUBO
PUBLISHED FOR OPPOSITION
08/15/2023
GPNX
NOTIFICATION PROCESSED BY IB
08/14/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/26/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/13/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/13/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/13/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/16/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/16/2023
RFNT
REFUSAL PROCESSED BY IB
01/09/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/16/2022
RFRR
REFUSAL PROCESSED BY MPU
12/16/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/13/2022
CNRT
NON-FINAL ACTION WRITTEN
09/12/2022
DOCK
ASSIGNED TO EXAMINER
09/06/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/15/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/10/2022
Continuous trademark protection
Get notified about every new filing that threatens SEFIRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.